Sinopharm
Sinopharm Group is engaged in the distribution of pharmaceutical products and medical equipment.
Business Model:
Revenue: $60.9B
Employees: 10,001-999,999
Rankings
Industries / Tags:
Detailed Sinopharm Information
Geographic Data
Address: No. 385 Longhua East Road
City: Shanghai
State: shanghai municipality
Zip: 200023
Country: CN
Financial Info
Stage:
post ipo equity
Raised Last:
$0
Raised Total:$0
Social
Metrics
3,399,566Website Global Rank
4,288Website Monthly Traffic
Twitter Followers
Description
Sinopharm Group is engaged in the distribution of pharmaceutical products and medical equipment.
Contact Phone:
Contact Email:
Sinopharm went public on 10/2/2009 on the Hong Kong Stock Exchange
Listed Exchange:
Hong Kong Stock Exchange
IPO Date:
10/2/2009
Ticker Symbol:
1099
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2016 | Ambrx | Venture Round | 0 |
| 2/2018 | Yes Skin Care Center | Series A | - |
| 7/2019 | GemPharmatech | Series A | 23.3M |
| 7/2019 | GemPharmatech | Series A | 0 |
| 2/2018 | Yes Skin Care Center | Series A | - |
| 8/2016 | Ambrx | Venture Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2015 | Post-IPO Equity | 1 | - |
Frontline BioVentures Frontline BioVentures |
12/2015 | Post-IPO Equity | 1 | - |
Frontline BioVentures Frontline BioVentures |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
